List of Tables
Summary Table A: Global Market for Antibiotics, by Product, Through 2027
Summary Table B: Global Market for Antibiotics, by Route of Administration, Through 2027
Table 1: Major Differences, Gram-Positive and Gram-Negative Organisms
Table 2: Proportion of Resistant Strains, by WHO Region
Table 3: Global Market for Antibiotics, by Product, Through 2027
Table 4: Global Market for Cell Wall Inhibitor, by Product, Through 2027
Table 5: Global Market for Cell Wall Inhibitors, by Region, Through 2027
Table 6: Global Market for Protein Inhibitors, by Product, Through 2027
Table 7: Global Market for Protein Inhibitors, by Region, Through 2025
Table 8: Global Market for DNA Inhibitors, by Product, Through 2027
Table 9: Global Market for DNA Inhibitors, by Region, Through 2027
Table 10: Global Market for Other Types of Inhibitors, by Region, Through 2027
Table 11: Global Market for Antibiotics, by Route of Administration, Through 2027
Table 12: Global Market for Antibiotics, by Region, Through 2027
Table 13: North American Market for Antibiotics, by Product, Through 2027
Table 14: North American Market for Antibiotics, by Country, Through 2027
Table 15: European Market for Antibiotics, by Product, Through 2025
Table 16: European Market for Antibiotics, by Country, Through 2025
Table 17: Asia-Pacific Market for Antibiotics, by Product, Through 2027
Table 18: Asia-Pacific Market for Antibiotics, by Country, Through 2027
Table 19: Latin American Market for Antibiotics, by Product, Through 2027
Table 20: Latin American Market for Antibiotics, by Country, Through 2025
Table 21: Middle Eastern and African Market for Antibiotics, by Product, Through 2027
Table 22: Middle Eastern and African Market for Antibiotics, by Country, Through 2027
Table 23: Antibiotics and Combinations in Global Clinical Development, Recent Approvals,2023
Table 24: FDA-approved Antibacterial Drugs, 2018
Table 25: FDA-Approved Antibacterial Drugs, 2019
Table 26: Abbott: Antibiotics Product Portfolio
Table 27: F. Hoffmann-La Roche AG: Antibiotics Product Portfolio
Table 28: GlaxoSmithKline Plc: Antibiotics Product Portfolio
Table 29: Johnson & Johnson: Antibiotics Product Portfolio
Table 30: Merck & Co. Inc.: Antibiotics Product Portfolio
Table 31: Merck & Co. Inc.: Antibiotic Drug Overview
Table 32: Pfizer Inc.: Antibiotics Product Portfolio
Table 33: Sanofi: Antibiotics Product Portfolio
Table 34: Sanofi S.A.: Antibiotic Drugs Overview
Table 35: Vitaris Inc.: Antibiotics Product Portfolio
Table 36: Acronyms Used in this Report
List of Figures
Summary Figure A: Global Market Shares of Antibiotics, by Product, 2021
Summary Figure B: Global Market Shares of Antibiotics, by Route of Administration, 2021
Figure 1: Types of Antibiotics, by Origin Source
Figure 2: Share of API Manufacturing Facilities for All Drugs, by Country/Region, Aug. 2019
Figure 3: Share of Population Aged 65+, by Region, 2019
Figure 4: Forecasted Share of Population Aged 65+, by Region, 2050
Figure 5: Increase in Elder Population, 2011 and 2050
Figure 6: Distribution of Population with Hospital-acquired Infections, U.S., 2020
Figure 7: Socioeconomic and Political Factors Contributing to Antibiotic Resistance
Figure 8: Global Market Shares of Antibiotics, by Product, 2021
Figure 9: Global Market Shares of Cell Wall Inhibitors, by Product, 2021
Figure 10: Global Market for Cell Wall Inhibitors, by Region, 2021-2027
Figure 11: Global Market Shares of Protein Inhibitors, by Product, 2021
Figure 12: Global Market for Protein Inhibitors, by Region, 2019-2027
Figure 13: Global Market Shares of DNA Inhibitors, by Product, 2019
Figure 14: Global Market for DNA Inhibitors, by Region, 2019-2027
Figure 15: Global Market for Other Types of Inhibitors, by Region, 2019-2027
Figure 16: Global Market Shares of Antibiotics, by Route of Administration, 2021
Figure 17: Global Market Shares of Antibiotics, by Region, 2021
Figure 18: North American Market Shares of Antibiotics, by Product, 2021
Figure 19: North American Market Shares of Cell Wall Inhibitors, by Product, 2021
Figure 20: North American Market Shares of Protein Inhibitors, by Product, 2021
Figure 21: North American Market Shares of DNA Inhibitors, by Product, 2021
Figure 22: North American Market Shares of Antibiotics, by Country, 2022
Figure 23: U.S. Market for Antibiotics, 2019-2027
Figure 24: Canadian Market for Antibiotics, 2019-2027
Figure 25: Mexican Market for Antibiotics, 2019-2027
Figure 26: European Market Shares of Antibiotics, by Product, 2021
Figure 27: European Market Shares of Cell Wall Inhibitors, by Product, 2021
Figure 28: European Market Shares of Protein Inhibitors, by Product, 2021
Figure 29: European Market Shares of DNA Inhibitors, by Product, 2021
Figure 30: European Market Shares of Antibiotics, by Country, 2021
Figure 31: German Market for Antibiotics, 2019-2027
Figure 32: French Market for Antibiotics, 2019-2027
Figure 33: U.K. Market for Antibiotics, 2019-2027
Figure 34: Italian Market for Antibiotics, 2019-2027
Figure 35: Spanish Market for Antibiotics, 2019-2027
Figure 36: Rest of European Market for Antibiotics, 2019-2027
Figure 37: Asia-Pacific Market Shares of Antibiotics, by Product, 2021
Figure 38: Asia-Pacific Market Shares of Cell Wall Inhibitors, by Product, 2021
Figure 39: Asia-Pacific Market Shares of Protein Inhibitors, by Product, 2021
Figure 40: Asia-Pacific Market Shares of DNA Inhibitors, by Product, 2021
Figure 41: Asia-Pacific Market Shares of Antibiotics, by Country, 2021
Figure 42: Japanese Market for Antibiotics, 2019-2027
Figure 43: Chinese Market for Antibiotics, 2019-2027
Figure 44: Indian Market for Antibiotics, 2019-2027
Figure 45: Australia and New Zealand Market for Antibiotics, 2019-2027
Figure 46: Rest of Asia-Pacific Market for Antibiotics, 2019-2027
Figure 47: Latin American Market Shares of Antibiotics, by Product, 2021
Figure 48: Latin American Market Shares of Cell Wall Inhibitors, by Product, 2021
Figure 49: Latin American Market Shares of Protein Inhibitors, by Product, 2021
Figure 50: Latin American Market Shares of DNA Inhibitors, by Product, 2021
Figure 51: Latin American Market Shares of Antibiotics, by Country, 2021
Figure 52: Brazilian Market for Antibiotics, 2019-2027
Figure 53: Argentinian Market for Antibiotics, 2019-2027
Figure 54: Rest of Latin American Market for Antibiotics, 2019-2027
Figure 55: Middle Eastern and African Market Shares of Antibiotics, by Product, 2021
Figure 56: Middle Eastern and African Market Shares of Cell Wall Inhibitors, by Product, 2021
Figure 57: Middle Eastern and African Market Shares of Protein Inhibitors, by Product, 2021
Figure 58: Middle Eastern and African Market Shares of DNA Inhibitors, by Product, 2021
Figure 59: Middle Eastern and African Market Shares of Antibiotics, by Country, 2021
Figure 60: GCC Countries’ Market for Antibiotics , 2019-2027
Figure 61: South African Market for Antibiotics, 2021-2027
Figure 62: Rest of Middle Eastern and African Market for Antibiotics, 2019-2027
Figure 63: Impact of COVID-19 on the Pharmaceutical Industry
Figure 64: Value Chain Analysis
Figure 65: Global Market Shares of Antibiotics, by Manufacturer, 2021
Figure 66: Abbott: Annual Revenue, 2019-2021
Figure 67: Abbott: Revenue Shares, by Country/Region, 2021
Figure 68: Abbott: Revenue Shares, by Business Unit, 2021
Figure 69: F. Hoffmann-La Roche AG: Annual Revenue, 2019-2022
Figure 70: F. Hoffmann-La Roche AG: Revenue Shares in Pharmaceutical Segment, by Country/Region, 2022
Figure 71: F. Hoffmann-La Roche AG: Revenue Shares, by Business Segment, 2022
Figure 72: F. Hoffmann-La Roche AG: Revenue Shares, by Therapeutic Segment, 2022
Figure 73: GlaxoSmithKline Plc: Annual Revenue, 2020-2022
Figure 74: GlaxoSmithKline Plc: Revenue Shares, by Pharmaceutical, 2022
Figure 75: GlaxoSmithKline Plc: Revenue Shares, by Product Category, 2022
Figure 76: GlaxoSmithKline Plc: Revenue Shares, by Region, 2022
Figure 77: Johnson & Johnson: Annual Revenue, 2019-2021
Figure 78: Johnson & Johnson: Revenue Shares, by Region, 2021
Figure 79: Johnson & Johnson: Revenue Shares, by Business Unit, 2021
Figure 80: Merck & Co. Inc.: Annual Revenue, 2020-2022
Figure 81: Merck & Co. Inc.: Revenue Shares, by Region, 2019
Figure 82: Merck & Co. Inc.: Revenue Shares, by Business Unit, 2019
Figure 83: Pfizer Inc.: Annual Revenue, 2020-2022
Figure 84: Pfizer Inc.: Revenue Shares, by Region, 2022
Figure 85: Pfizer Inc.: Revenue Shares, by Country, 2022
Figure 86: Pfizer Inc.: Revenue Shares, by Business Segment, 2022
Figure 87: Sanofi: Annual Revenue, 2020-2022
Figure 88: Sanofi: Revenue Shares, by Region/Country, 2022
Figure 89: Sanofi: Revenue Shares, by Business Segment, 2022
Figure 90: Viatris Inc.: Annual Revenue, 2020-2022
Figure 91: Vitaris Inc.: Revenue Shares, by Region, 2022
Figure 92: Vitaris Inc.: Revenue Shares, by Business Unit, 2022
